Department of the Army March 25, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 4 of 4
Availability of Non-Exclusive, Exclusive License or Partially Exclusive Licensing of U.S. Patent Concerning Combined In-Plane Shear and Multi-Axial Tension or Compression Testing Apparatus
In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent No. US 6,860,156 B1 entitled ``Combined In-Plane Shear and Multi-Axial Tension or Compression Testing Apparatus'' issued March 1, 2005. This patent has been assigned to the United States Government as represented by the Secretary of the Navy.
NAF Contracting Regulation, AR 215-4
This publication was last published October 10, 1990. It has been updated and revised to include best value acquisition practices, acquisition streamlining, participation in the government/ nonappropriated fund (NAF) purchase card program, implementation of a NAF automated procurement system, and reassignment of signature authority in keeping with the Army's recent restructuring that resulted in the establishment of the new Installation Management Agency (IMA). The public was not and will not be invited to comment on AR 215-4, NAF Contracting Regulation. Although the policy contained in this regulation affects the public as defined in Title 44, this regulation will not be codified. This notice is being published for the purpose of notifying the public as to how Nonapproporiated Fund Contracting activities will conduct its business.
Command and General Staff College Advisory Committee
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 463) announcement is made of the following committee meeting: Name of Committee: U.S. Army Command and General Staff College (CGSC) Advisory Committee. Date of Meeting: April 18-20, 2005. Place of Meeting: Bell Hall, Room 113, Fort Leavenworth, KS 66027- 1352. Time of Meeting: 3 p.m.-5 p.m. (April 18, 2005); 7:30 a.m.-5 p.m. (April 19, 2005); and 7:30 a.m.-2 p.m. (April 20, 2005). Proposed Agenda: Review of CGSC educational program and Executive Session and Report to Commandant (10 a.m.-12 p.m., April 20, 2005).
Intent To Grant an Exclusive License of a U.S. Government-Owned Patent
In accordance with 35 U.S.C. 209 and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license within the geographic area of the United States of America and its territories and possessions to U.S. Provisional Patent S.N. 60/533,375, filed April 13, 2004 entitled ``Marburg Virus-Like Particles as a Vaccine for Prevention of Lethal Marburg Virus Disease,'' U.S. Patent application 10/289,839, filed November 7, 2002 entitled ``Generation of Virus-like Particles and Demonstration of Lipid Rafts as Sites of Filovirus Entry and Budding,'' and U.S. Patent application 10/066,506, filed January 31, 2002 entitled, ``Chimeric Filovirus Glycoprotein,'' for the specific claims and use related to the virus-like particle technology described therein, to be limited to the field of use of developing and commercializing prophylactic (preventative) vaccines and immunotherapties (active and passive) against the Ebola and Marburg filoviruses, individually or jointly to Virionics Corporation with its principal place of business at 19108 Barksdale Court, Germantown, MD 20874-1526.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
